| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2605 | 2019 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 820 | 2021 |
| Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 131-138, 2019 | 601 | 2019 |
| Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study COVIDSurg Collaborative Anaesthesia 76 (6), 748-758, 2021 | 589* | 2021 |
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 477 | 2011 |
| Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ... The Lancet infectious diseases 19 (2), 143-155, 2019 | 403 | 2019 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodriguez-Bano, I Jarrín, J Carratala, J Pachon, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 380 | 2020 |
| Effect of noninvasive respiratory strategies on intubation or mortality among patients with acute hypoxemic respiratory failure and COVID-19: the RECOVERY-RS randomized … GD Perkins, C Ji, BA Connolly, K Couper, R Lall, JK Baillie, JM Bradley, ... Jama 327 (6), 546-558, 2022 | 347 | 2022 |
| European guidelines on the clinical management of HIV-1 tropism testing LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vézinet, B Clotet, ... The Lancet infectious diseases 11 (5), 394-407, 2011 | 318 | 2011 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 191 | 2016 |
| Safety and efficacy of fluoxetine on functional outcome after acute stroke (AFFINITY): a randomised, double-blind, placebo-controlled trial GJ Hankey, ML Hackett, OP Almeida, L Flicker, GE Mead, MS Dennis, ... The Lancet Neurology 19 (8), 651-660, 2020 | 137 | 2020 |
| Dual therapy with darunavir and ritonavir plus lamivudine vs triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir and … F Pulido, E Ribera, M Lagarde, I Pérez-Valero, R Palacios, JA Iribarren, ... Clinical Infectious Diseases 65 (12), 2112-2118, 2017 | 136* | 2017 |
| Long-term (180-day) outcomes in critically ill patients with COVID-19 in the REMAP-CAP randomized clinical trial S Florescu, D Stanciu, M Zaharia, A Kosa, D Codreanu, A Kidwai, ... Jama 329 (1), 39-51, 2023 | 117 | 2023 |
| Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality T Nakanishi, S Pigazzini, F Degenhardt, M Cordioli, G Butler-Laporte, ... The Journal of clinical investigation 131 (23), 2021 | 111 | 2021 |
| SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study. C COVIDSurg, C GlobalSurg Anaesthesia 77 (1), 28-39, 2022 | 109 | 2022 |
| Impact of late presentation of HIV infection on short-, mid-and long-term mortality and causes of death in a multicenter national cohort: 2004–2013 P Sobrino-Vegas, S Moreno, R Rubio, P Viciana, JI Bernardino, ... Journal of Infection 72 (5), 587-596, 2016 | 104 | 2016 |
| Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study RK Lodwick, CA Sabin, K Porter, B Ledergerber, A Van Sighem, ... The Lancet 376 (9738), 340-345, 2010 | 98 | 2010 |
| Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance C de Mendoza, C Rodriguez, F García, JM Eiros, L Ruíz, E Caballero, ... Journal of antimicrobial chemotherapy 59 (4), 698-704, 2007 | 94 | 2007 |
| Detailed stratified GWAS analysis for severe COVID-19 in four European populations F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ... Human molecular genetics 31 (23), 3945-3966, 2022 | 89* | 2022 |
| Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study B Gutiérrez-Gutiérrez, MD Del Toro, AM Borobia, A Carcas, I Jarrín, ... The Lancet infectious diseases 21 (6), 783-792, 2021 | 85 | 2021 |
